
5-Methyl-2'-deoxycytidine | CAS:838-07-3
5-Methyl-2'-deoxycytidine
- Name:5-Methyl-2'-deoxycytidine
- CAS:838-07-3
- Synonyms:2'-Deoxy-5-methylcytidine
- Molecular Formula:C10H15N3O4
- Molecular Weight:241.24
- EINESC:212-655-1
Description
Properties
没有数据 | 没有数据 |
---|
Safety
没有数据 | 没有数据 |
---|
SDS
Source | SDS/MSDS Samples |
---|---|
Alfa-Aesar | View & Download |
Sigma-Aldrich | View & Download |
TCI | View & Download |
Synthetic Route
Name | CAS |
---|
More
Articles
Peer-Reviewed Papers
Topical sensitizers in alopecia areata.Amy J McMichael et al.Dermatology nursing, 16(4), 333-336 (2004-10-09)
Adjunctive trichloroacetic acid therapy enhances squaric acid response to verruca vulgaris.Jonathan I Silverberg et al.Journal of drugs in dermatology : JDD, 11(10), 1228-1230 (2012-11-09)
Lentiginous eruption due to topical immunotherapy.Antonella Tosti et al.Archives of dermatology, 139(4), 544-545 (2003-04-23)
Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata.M Zöller et al.Clinical and experimental immunology, 135(3), 398-408 (2004-03-11)
Prolonged dermatitis distant to the site of squaric acid dibutyl ester applications and recovery of alopecia areata.H Ujiie et al.Clinical and experimental dermatology, 30(5), 579-580 (2005-07-28)
Adult and paediatric contact immunotherapy with squaric acid dibutylester (SADBE) for recurrent, multiple, resistant, mucocutaneous anogenital warts.F Dall' Oglio et al.Sexually transmitted infections, 78(4), 309-310 (2002-08-16)
Synthesis of novel squaraine dyes and their intermediates. Tatarets AL, et al. Dyes and Pigments, 64(2), 125-134 (2005)
Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases.Shigeki Inui et al.The Journal of dermatology, 36(6), 323-327 (2009-06-09)
Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata.Yayoi Shimaoka et al.The Journal of dermatology, 35(3), 151-153 (2008-03-19)
Contact immunotherapy-induced Renbök phenomenon in a patient with alopecia areata and psoriasis vulgaris.Taisuke Ito et al.European journal of dermatology : EJD, 20(1), 126-127 (2009-10-14)
A chronic contact eczema impedes migration of antigen-presenting cells in alopecia areata.Pooja Gupta et al.The Journal of investigative dermatology, 126(7), 1559-1573 (2006-05-06)
Alopecia areata triggered or exacerbated by swine flu virus infection.Taisuke Ito et al.The Journal of dermatology, 39(10), 863-864 (2011-12-07)
Treatment of alopecia areata in children.Niyati Mukherjee et al.Pediatric annals, 38(7), 388-395 (2009-08-19)
Topical immunotherapy with contact sensitizers: a model to study the natural history of delayed hypersensitivity.M Mastrolonardo et al.Contact dermatitis, 47(4), 210-214 (2002-12-21)
Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): results of an open-label, paired-comparison, clinical trial.F Dall'oglio et al.The Journal of dermatological treatment, 16(1), 10-14 (2005-05-18)
Delayed type hypersensitivity-induced myeloid-derived suppressor cells regulate autoreactive T cells.Vibhuti Singh et al.European journal of immunology, 41(10), 2871-2882 (2011-07-06)
Molecular and crystal structure of 3-butoxy-4-(1, 3, 3-trimethyl-2, 3-dihydro-1H-2-indolylidenemethyl)-3-cyclobutene-1, 2-dione and its thio analog. Shishkina SV, et al. Journal of Structural Chemistry, 46(1), 154-158 (2005)
Biphenyls as potent vitronectin receptor antagonists. Part 3: Squaric acid amides.Klaus Urbahns et al.Bioorganic & medicinal chemistry letters, 17(22), 6151-6154 (2007-10-04)
Usefulness of topical immunotherapy with squaric acid dibutylester for refractory common warts on the face and neck.Naoto Hama et al.The Journal of dermatology, 36(12), 660-662 (2009-12-05)
Determination of in vivo dose response and allergen-specific T cells in subjects contact-sensitized to squaric acid dibutyl ester.Melissa M Camouse et al.Dermatitis : contact, atopic, occupational, drug, 19(2), 95-99 (2008-04-17)
Cutaneous lymphoid hyperplasia related to squaric acid dibutyl ester.Eric A Millican et al.Journal of the American Academy of Dermatology, 65(1), 230-232 (2011-06-18)
Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.Kazumasa Morita et al.The Journal of dermatology, 29(10), 661-664 (2002-11-16)
Insights into the quantitative relationship between sensitization and challenge for allergic contact dermatitis reactions.Aaron E Scott et al.Toxicology and applied pharmacology, 183(1), 66-70 (2002-09-10)
The importance of myeloid-derived suppressor cells in the regulation of autoimmune effector cells by a chronic contact eczema.Rachid Marhaba et al.Journal of immunology (Baltimore, Md. : 1950), 179(8), 5071-5081 (2007-10-04)
The pattern and profile of alopecia areata in Singapore--a study of 219 Asians.Eileen Tan et al.International journal of dermatology, 41(11), 748-753 (2002-11-28)
A benzothiazole-based semisquarylium dye suitable for highly selective Hg2+ sensing in aqueous media. Bae J-S, et al. Dyes and Pigments, 83(3), 324-327 (2009)
Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in Alopecia areata and factors influencing the outcome.C Ajith et al.Journal of drugs in dermatology : JDD, 5(3), 262-266 (2006-04-01)
Immunotherapy for childhood warts.David A Dasher et al.Pediatric annals, 38(7), 373-379 (2009-08-19)
Remarks
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
Name | CAS |
---|

Related Products
Related News
Question
Hot Tags
Inquiry
Fill in related informations ;please!
- Please fill in product name !
- CAS
- Please fill in your company information correctly!
- Please fill in liaison information correctly!
- Please fill in your telephone number correctly!
- Please fill in your email correctly!
- Please describe the problem of products!